Prevalence of anti HCV, HBsAg and HIV antibodies in high risk recipients of blood and blood products.

Chakrabarti, S; Pradhan, P; Roy, A; Hira, M; Bandyopadhyay, G; Bhattacharya, D K

Prevalence of anti HCV, HBsAg and HIV antibodies in high risk recipients of blood and blood products.

Date

2006-01-30

Authors

Abstract

Along with hepatitis B virus (HBV) and human immunodeficiency virus (HIV), Hepatitis C virus (HCV) is emerging as a major transfusion hazard. 22 cases of haemophilia (A 19, B 3) and 20 cases of thalassaemia (2 16, E(2) 4) constituted the study group. Patients tested for anti HCV (using third generation ELISA), HBsAg and antibodies to HIV I and II. Prevalence of anti HCV was 54.5% in haemophilics and 5% in thalassaemics. HBsAg was detected in 9.09% haemophilics and 5% thalassaemics. No anti HIV was detected in this cohort. Anti HCV seropositivity in haemophilics has increased compare to previous studies.

Citation

Chakrabarti S, Pradhan P, Roy A, Hira M, Bandyopadhyay G, Bhattacharya DK. Prevalence of anti HCV, HBsAg and HIV antibodies in high risk recipients of blood and blood products. Indian Journal of Public Health. 2006 Jan-Mar; 50(1): 43-4